Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8

The use of molecular-targeted drugs in the treatment of gastric cancer is increasing. However, the variety of molecular-targeted drugs in gastric cancer is still limited, and the development of new molecular-targeted therapies is required. The effect of combining sunitinib (SUN) with pterostilbene (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hojo, Yudai, Kishi, Shingo, Mori, Shiori, Fujiwara-Tani, Rina, Sasaki, Takamitsu, Fujii, Kiyomu, Nishiguchi, Yukiko, Nakashima, Chie, Luo, Yi, Shinohara, Hisashi, Kuniyasu, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999764/
https://www.ncbi.nlm.nih.gov/pubmed/35409367
http://dx.doi.org/10.3390/ijms23074002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999764/
https://www.ncbi.nlm.nih.gov/pubmed/35409367
http://dx.doi.org/10.3390/ijms23074002

Ejemplares similares